RE:Copied from TweeterThe 35 page OLC -Memo for the Attorney General- and the 252 paeg FDA-HHS review will be close to impossible for any litigation to over-turn. While a Final Rule timeline is uncertain, there will be plenty of challenges and delays. The conclusion of Schedule III is clear. Im sure all challanges would be settled quick and if they want to take it to the SCOTUS we will win. Just to add The Galand Memo will give us custody maybe not uplisting. Time line for the Garland Memo is unclear, could be days could be mths? No more paying 280E tax is a saving of $12.5-Mil a mth for CURA. and we should be getting back pay from past yrs. Looking at the whole picture there is really nothing that will stand in the way, the IRS, HHS, FDA, DEA & President Biden are all for Re-Scheduling- to 3 . My question is; Who the heck is going to stand in the way of these firms in giving custody or even uplisting? Last Question I have is who is going to score Curaleaf first? Will it be the NASDAQ or will it be NYSE, let the courting begin. I do not see who is going to stand in the way?